Press Releases

Press Releases

March 23, 2016
Quanterix announces it has secured $46 million in Series D funding from both new and existing investors. This infusion of capital will allow Quanterix to build on the significant growth realized in the last two years.
November 3, 2016
Following the Company's successful participation in the Powering Precision Health Summit, Quanterix is bringing its insights and innovations to the West Coast
May 9, 2017
Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced that Smithers Avanza , a contract research organization supporting the pharmaceutical industry, is adding the Simoa HD-1 Analyzer to its Bioanalytical Laboratory. With this…
Business Wire
New benchtop design and expanded assay portfolio offers researchers greater access to ultra-sensitive Simoa technology for unrivaled biomarker detection
CAMBRIDGE, MA – May 23, 2010 – Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company’s proprietary technology that demonstrates an unprecedented sensitivity…
CAMBRIDGE, MA and SALZBURG, Austria – July 20, 2011 – Quanterix Corporation, enabling a new generation of diagnostic tests based on the revolutionary Single Molecule Array (SiMoA™) technology, and Sony DADC Austria AG, today announced that they have entered into a collaboration for the development…
CAMBRIDGE, MA – December 22, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, has reported a method for detecting individual proteins within microfabricated polymer arrays produced…
LEXINGTON, Mass., January 22, 2013 – Quanterix Corporation announced today that Analytical Chemistry has published a ground-breaking study in which its Simoa technology was used to directly measure bacterial genomic DNA of S. aureus in both human blood and river water at sub-femtomolar…
Lexington, Mass. – February 20, 2014 – Quanterix Corporation, Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it was one of the 33 recipients of the Massachusetts Life…
CHICAGO– December 18, 2014 Ten scientists are being honored as finalists for the 2015 SLAS Innovation Award, with the winner to be identified at the closing session of SLAS2015. The winner will receive a $10,000 cash prize along with having their name added to the prestigious list of previous…